- Home
- AIRS vs SWKH Comparison
AIRS vs SWKH Comparison
Compare AIRS & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- SWKH
- Stock Information
- Founded
- AIRS 2012
- SWKH 1996
- Country
- AIRS United States
- SWKH United States
- Employees
- AIRS N/A
- SWKH N/A
- Industry
- AIRS Medical/Nursing Services
- SWKH Diversified Financial Services
- Sector
- AIRS Health Care
- SWKH Finance
- Exchange
- AIRS Nasdaq
- SWKH Nasdaq
- Market Cap
- AIRS 166.3M
- SWKH 179.1M
- IPO Year
- AIRS 2021
- SWKH 1999
- Fundamental
- Price
- AIRS $6.45
- SWKH $14.87
- Analyst Decision
- AIRS Hold
- SWKH Strong Buy
- Analyst Count
- AIRS 3
- SWKH 1
- Target Price
- AIRS $3.75
- SWKH $18.00
- AVG Volume (30 Days)
- AIRS 724.6K
- SWKH 13.9K
- Earning Date
- AIRS 08-01-2025
- SWKH 08-14-2025
- Dividend Yield
- AIRS N/A
- SWKH N/A
- EPS Growth
- AIRS N/A
- SWKH 55.18
- EPS
- AIRS N/A
- SWKH 1.41
- Revenue
- AIRS $165,109,000.00
- SWKH $37,409,000.00
- Revenue This Year
- AIRS N/A
- SWKH $52.93
- Revenue Next Year
- AIRS $5.14
- SWKH N/A
- P/E Ratio
- AIRS N/A
- SWKH $10.55
- Revenue Growth
- AIRS N/A
- SWKH 47.31
- 52 Week Low
- AIRS $1.53
- SWKH $12.00
- 52 Week High
- AIRS $9.20
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- AIRS 53.51
- SWKH 54.95
- Support Level
- AIRS $5.80
- SWKH $14.38
- Resistance Level
- AIRS $6.90
- SWKH $14.84
- Average True Range (ATR)
- AIRS 0.53
- SWKH 0.27
- MACD
- AIRS -0.03
- SWKH 0.04
- Stochastic Oscillator
- AIRS 38.92
- SWKH 98.92
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.